ES2083478T3 - Antagonistas de nmda heterociclicos. - Google Patents

Antagonistas de nmda heterociclicos.

Info

Publication number
ES2083478T3
ES2083478T3 ES91107955T ES91107955T ES2083478T3 ES 2083478 T3 ES2083478 T3 ES 2083478T3 ES 91107955 T ES91107955 T ES 91107955T ES 91107955 T ES91107955 T ES 91107955T ES 2083478 T3 ES2083478 T3 ES 2083478T3
Authority
ES
Spain
Prior art keywords
antagonists
nmta
cyclical
hetero
phosphono
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91107955T
Other languages
English (en)
Inventor
Jeffrey P Whitten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2083478T3 publication Critical patent/ES2083478T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA CLASE DE 3-FOSFORO-PIPERIDINA Y DERIVADOS DE PIRROLIDINA Y SU USO COMO ANTAGONISTAS DE NMDA.
ES91107955T 1990-05-17 1991-05-16 Antagonistas de nmda heterociclicos. Expired - Lifetime ES2083478T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52529090A 1990-05-17 1990-05-17
US07/675,156 US5194430A (en) 1990-05-17 1991-03-28 Heterocyclic-nmda antagonists

Publications (1)

Publication Number Publication Date
ES2083478T3 true ES2083478T3 (es) 1996-04-16

Family

ID=27061745

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91107955T Expired - Lifetime ES2083478T3 (es) 1990-05-17 1991-05-16 Antagonistas de nmda heterociclicos.

Country Status (20)

Country Link
US (2) US5194430A (es)
EP (1) EP0457324B1 (es)
JP (1) JP2977950B2 (es)
KR (1) KR100196239B1 (es)
CN (1) CN1027695C (es)
AT (1) ATE131172T1 (es)
AU (1) AU641657B2 (es)
CA (1) CA2042473C (es)
DE (1) DE69115116T2 (es)
DK (1) DK0457324T3 (es)
ES (1) ES2083478T3 (es)
FI (1) FI97388C (es)
GR (1) GR3019047T3 (es)
HU (1) HU208831B (es)
IE (1) IE70437B1 (es)
IL (1) IL98148A (es)
NO (1) NO300502B1 (es)
NZ (1) NZ238124A (es)
PT (1) PT97692B (es)
TW (1) TW308596B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260286A (en) * 1992-10-16 1993-11-09 Japan Tobacco, Inc. 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists
AU2002250256B2 (en) * 2001-03-08 2008-04-03 Emory University pH-dependent NMDA receptor antagonists
US8420680B2 (en) 2007-06-29 2013-04-16 Emory University NMDA receptor antagonists for neuroprotection
CN102952130B (zh) * 2011-08-24 2016-03-23 重庆华邦胜凯制药有限公司 手性合成(s,s)-2,8-二氮杂双环壬烷的方法
CN102952065A (zh) * 2011-08-24 2013-03-06 重庆华邦胜凯制药有限公司 一种拆分顺式2,3-吡啶二甲酸酯的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2706194A (en) * 1951-05-14 1955-04-12 Shell Dev Esters of phosphonic acids
NL299936A (es) * 1963-10-30 1965-08-25
JPS5251028A (en) * 1975-10-22 1977-04-23 Nippon Tokushu Noyaku Seizo Kk Herbicide
US4094974A (en) * 1977-02-24 1978-06-13 Stauffer Chemical Company Isoxazole phosphates and phosphonates
US4139708A (en) * 1977-05-24 1979-02-13 Sk&F Lab Co. Intermediates and processes useful for preparing medicinal agents imidazolemethylphosphonium salts
CA1248531A (en) * 1984-04-17 1989-01-10 Jeffrey C. Watkins 4-substituted piperazine-2-carboxylic acids
US4906621A (en) * 1985-05-24 1990-03-06 Ciba-Geigy Corporation Certain 2-carboxypiperidyl-alkylene phosphonic acids and esters thereof useful for the treatment of disorders responsive to N-methyl-D-aspartate receptor blockade
PH23848A (en) * 1985-05-24 1989-11-23 Ciba Geigy Ag Certain phosphonic acids and derivatives
US4746653A (en) * 1986-02-28 1988-05-24 Ciba-Geigy Corporation Certain hetero phosphonic acid derivatives of 2-piperidine or 2-tetrahydropyridinecarboxylates and esters thereof which are useful for the treatment of disorders responsive to blockade of the NMDA receptor in mammals
US4657899A (en) * 1986-04-09 1987-04-14 Nova Pharmaceutical Corporation Antagonists of specific excitatory amino acid neurotransmitter receptors
ATE60776T1 (de) * 1986-11-21 1991-02-15 Ciba Geigy Ag Ungesaettigte phosphonsaeure und derivate.
SE9003652D0 (sv) * 1990-11-15 1990-11-15 Astra Ab New heterocyclic compounds

Also Published As

Publication number Publication date
KR100196239B1 (ko) 1999-06-15
NO911916D0 (no) 1991-05-16
US5194430A (en) 1993-03-16
PT97692A (pt) 1992-02-28
NO300502B1 (no) 1997-06-09
KR910020023A (ko) 1991-12-19
CN1027695C (zh) 1995-02-22
EP0457324B1 (en) 1995-12-06
FI912382A0 (fi) 1991-05-16
NO911916L (no) 1991-11-18
JP2977950B2 (ja) 1999-11-15
NZ238124A (en) 1993-09-27
FI912382A (fi) 1991-11-18
IE911676A1 (en) 1991-11-20
AU641657B2 (en) 1993-09-30
ATE131172T1 (de) 1995-12-15
CA2042473C (en) 2002-01-01
GR3019047T3 (en) 1996-05-31
HU208831B (en) 1994-01-28
FI97388C (fi) 1996-12-10
IL98148A (en) 1996-10-16
DE69115116D1 (de) 1996-01-18
IE70437B1 (en) 1996-11-27
US5470844A (en) 1995-11-28
FI97388B (fi) 1996-08-30
JPH0812691A (ja) 1996-01-16
CN1056499A (zh) 1991-11-27
DE69115116T2 (de) 1996-06-13
DK0457324T3 (da) 1996-01-02
TW308596B (es) 1997-06-21
PT97692B (pt) 1998-09-30
EP0457324A1 (en) 1991-11-21
CA2042473A1 (en) 1991-11-18
AU7649891A (en) 1991-11-21
HUT59150A (en) 1992-04-28
HU911649D0 (en) 1991-11-28

Similar Documents

Publication Publication Date Title
PT641343E (pt) Derivados de 4-mercaptoacetilamino-¬2|benzazapinona (3) e a sua utilizacao como inibidores de encefalinase
NO930035D0 (no) Eksitatoriske aminosyreantagonister
ES2072607T3 (es) Derivados 3 indolil tioacetato.
DE69230224D1 (de) Potenzierung von nmda-antagonisten
DK0406211T3 (da) Fucosidase-inhibitorer
ES2083478T3 (es) Antagonistas de nmda heterociclicos.
ATE137225T1 (de) Dihydrochinolin nmda antagonisten
DK0532629T3 (da) 1-Piperidinyl-alkanoylarylsulfonamid-derivater
MX9302878A (es) Procedimiento para la preparacion de un diaminodiol substituido.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 457324

Country of ref document: ES